GSK building. Photo: nitpicker/Shutterstock
Brazil’s federal health regulator Anvisa signed off on clinical trials for a new potential coronavirus vaccine, developed by pharmaceutical companies Medicago, from Canada, and GlaxoSmithKline (GSK), from the United Kingdom.
The vaccine will be administered in two shots, over a period of 21 days. Anvisa claims phase 1 and 2 trial data “presented a safety profile acceptable for potential vaccines.”
Phase 3 trials will include up to 30,000 volunteers in Canada, the U.S., Latin America, and Europe.
In 2000, Formula 1 great Michael Schumacher had just racked up his 41st race win,…
Overall, the worldwide economic outlook has improved according to the Organization for Economic Co-operation and…
“This is f***ing corruption, it has to change,” protested an irate John Textor, owner of…
Eduardo Leite, governor of the southern Brazilian state of Rio Grande do Sul, on Wednesday…
Moody’s is the latest rating agency to improve its assessment of Brazil, bumping up the…
Other finalists include the Harvard Business Review, Fortune, Condé Nast, and the NFL